Tag:

Bayer

Latest Headlines

Latest Headlines

Bayer rolls up its sleeves for major reorg after plastics unit departs

After Bayer hives off its plastics business, it's going to remake the rest. The German conglomerate will merge its HealthCare and CropScience divisions into one life-science-focused company, and if sales are any indication, the health side of things will dominate.

Bayer, J&J launch new stroke study to pump up payer-persuading Xarelto data

Bayer and Johnson & Johnson have plunked down hundreds of millions to study the anticoagulant Xarelto for one use after another. Armed with more indications than any of its warfarin-alternative rivals, Xarelto now has the biggest share of that market.

Bayer study reveals growth opportunity for vet clinics in fighting parasites

A survey of 2,000 pet owners conducted by Bayer HealthCare Animal Health and the Companion Animal Parasite Council has revealed that when veterinarians provide information to clients about parasites prevalent in their area, they can drive up clinic visits.

How much for docs speaking on Eliquis, Xarelto and Pradaxa? $20M and counting

If you've watched television lately, you know that Pfizer and Bristol-Myers have been spending a lot of money on advertising to back their new anticoagulant, Eliquis. So have rival Boehringer Ingelheim, with its Pradaxa drug, and Bayer and Johnson & Johnson with Xarelto.

Whistle-blowing Bayer sales rep wins again in wrongful termination suit

Was it the canceled credit card? Or was it the whistleblowing? Those were the big questions in a former Bayer HealthCare sales rep's wrongful termination suit--and though Bayer's appeal in the case technically rested on different questions, the credit card and the whistleblowing were central to it all the same.

Bayer drafts 'Community' star to launch cult-favorite hangover cure in U.S.

Bayer, gunning for the world lead in consumer health, is bringing a product to the U.S. that should help toward that goal: a dissolvable orange disc that transforms a plain glass of water into one of the world's preferred hangover elixirs.

Bayer shuffles agency assignments to fold in Merck OTC brands

Bayer, which picked up Merck's consumer health unit in a $14.2 billion deal this spring, wanted to fold in all the brands from the New Jersey pharma giant's lineup. But to do so, it had to do some creative assignment shuffling. And its agencies had to take some creative steps of their own.

'Futuristic' treatments come to fruition with cell and gene therapies

The world of gene therapy--in which single-dose treatments correct debilitating defects--enjoyed something of a renaissance in 2014. Strong clinical results from leaders in the once-maligned field spurred renewed optimism, helping a new generation of startups secure millions in venture financing to develop their next-generation approaches to the field.

BBDO and JWT win, Havas loses as Bayer divvies up Merck's former OTC brands

Bayer, which picked up Merck's consumer health unit in a $14.2 billion deal this spring, wanted to fold in all the brands from the New Jersey pharma giant's lineup. But to do so, it had to do some creative assignment shuffling. And its agencies had to take some creative steps of their own.

Bayer casts off equine drugs with 'no strategic relevance' to Sanofi's Merial

Bayer HealthCare announced Wednesday that it is handing its equine products Legend/Hyonate (hyaluronate sodium) and Marquis (ponazuril) to Sanofi's animal health company, Merial.